The Ujjayi Pranayama for Hypothyroidism Study: Yogic Breathing, Thyroid Balance, Autonomic regulation and Metabolic Health

1. Overview

Reason Behind the Study

Hypothyroidism, a condition in which the thyroid gland fails to produce sufficient thyroid hormones, represents one of the most prevalent endocrine disorders globally, with a pronounced predilection for women. Standard treatment relies on levothyroxine supplementation, which replaces the deficient thyroxine (T4) and normalizes thyroid-stimulating hormone (TSH) levels. However, many patients continue to experience residual symptoms including persistent fatigue, unexplained weight gain, cold intolerance, and reduced quality of life despite achieving biochemically normal thyroid profiles. This discrepancy between laboratory values and symptomatic experience has driven interest in complementary approaches that address the broader physiological dysregulation accompanying hypothyroidism, particularly autonomic nervous system imbalance. Approximately 65 percent of overt hypothyroid patients exhibit autonomic dysfunction characterized by sympathetic overactivity and parasympathetic withdrawal, a state of sympathovagal imbalance that independently increases cardiovascular risk . Pranayama, the yogic science of breath regulation, has long been hypothesized to modulate autonomic function through deliberate manipulation of respiratory patterns. Ujjayi pranayama, often translated as victorious breath or ocean breath, involves a gentle constriction of the glottis during both inhalation and exhalation, producing a soft audible sound and prolonging the breath cycle. Despite centuries of traditional use, rigorous scientific investigation into its effects on thyroid function remained sparse.

Goals

The study by Thenmozhi P and J. Cathrin, conducted at the Saveetha Institute of Medical and Technical Sciences and published in the proceedings of the 2025 International Conference on Ambient Intelligence in Health Care, aimed to quantify the impact of a structured Ujjayi pranayama intervention on two specific outcomes in patients with diagnosed hypothyroidism: thyroid profile parameters (T3, T4, and TSH) and body mass index . The researchers sought to determine whether this single breathing technique, practiced consistently over a defined period, could produce measurable changes in thyroid hormone levels and body weight, thereby providing evidence for its potential role as an adjunctive therapy alongside conventional pharmacological treatment.

Key Eye-Opening Findings

The study produced results that, while drawn from a small sample, suggested a physiologically meaningful pattern. After four weeks of daily Ujjayi pranayama practice, participants demonstrated statistically significant reductions in TSH and BMI, with p-values below 0.001 . T3 and T4 scores also showed significant decreases, an initially counterintuitive finding that the researchers interpreted as a shift toward a regulated therapeutic range rather than a simple increase in hormone output. A separate, methodologically more robust randomized controlled trial conducted over 12 weeks with 120 participants corroborated and extended these findings. In that study, TSH levels dropped significantly, T3 levels rose significantly, and body weight and BMI were reduced in the Ujjayi group compared to controls receiving only standard drug therapy . Notably, a complementary 2025 randomized trial demonstrated that three months of yoga therapy, including pranayama, significantly enhanced cardiac autonomic function in female hypothyroid patients, shifting the autonomic balance toward parasympathetic predominance and improving baroreflex sensitivity, thereby providing a mechanistic bridge between breath practice and thyroid regulation .

2. Study in Detail

Design and Participants

The primary study under examination employed an experimental research approach with a single-group pre-test post-test design. Thirty patients with diagnosed hypothyroidism were recruited from a primary health centre. The sample was overwhelmingly female at 93 percent, consistent with the known epidemiological sex distribution of hypothyroidism. The mean age of participants was 49 years with a standard deviation of 3.62 years . A parallel and more methodologically rigorous investigation, a randomized controlled trial by Venkateswaran and colleagues, enrolled 120 participants—60 in a study group and 60 in a control group—all within the age range of 18 to 55 years. Only patients already receiving standard hypothyroidism medication were included, and the Ujjayi intervention was administered as an adjunct rather than a replacement for pharmacological therapy .

Methodology

The Thenmozhi and Cathrin protocol involved daily Ujjayi pranayama practice for four weeks. Baseline measurements of thyroid profile, including T3, T4, and TSH, and body mass index were taken before the intervention commenced and again at the conclusion of the four-week period. Data analysis employed both descriptive and inferential statistical methods using SPSS software version 16 .

The Venkateswaran randomized controlled trial utilized a more extended 12-week protocol. Participants in the study group practiced Ujjayi pranayama for 15 minutes twice daily on six days each week for 90 days, in addition to their standard medication. The control group received standard medication without the breathing intervention. Outcomes assessed included T3, T4, TSH, body weight, and BMI, measured before and after the intervention period. Statistical significance was determined through pre-post comparisons within and between groups .

Physiological Rationale

The hypothesized mechanism connecting Ujjayi pranayama to thyroid function involves the autonomic nervous system. The throat, where the glottis is gently constricted during Ujjayi practice, houses the thyroid gland and is richly innervated by autonomic fibers. Ujjayi breathing, by prolonging exhalation and introducing a subtle airway resistance, is known to activate the vagus nerve and shift autonomic balance toward parasympathetic dominance . This shift may enhance blood flow to the thyroid region, modulate the hypothalamic-pituitary-thyroid (HPT) axis, reduce oxidative stress, and optimize metabolic regulation .

3. Key Findings

TSH Reduction Achieved Statistical Significance

The primary study demonstrated a significant reduction in TSH levels following the four-week intervention, with a p-value below 0.001 . The larger 12-week randomized controlled trial corroborated this finding, showing significant TSH reduction in the Ujjayi group compared to controls receiving medication alone . Elevated TSH is the hallmark laboratory finding in primary hypothyroidism, indicating that the pituitary gland is signaling for more thyroid hormone production. A reduction in TSH toward normal ranges suggests improved thyroid axis function and better cellular thyroid hormone availability.

T3 and T4 Changes Indicated Regulatory Shift

The findings regarding T3 and T4 require nuanced interpretation. The primary study reported significant decreases in T3 and T4 alongside the TSH reduction . While T3 and T4 decreases might appear paradoxical for a hypothyroid population, they must be understood in the context of TSH normalization. In patients already receiving levothyroxine supplementation, TSH is the more clinically relevant marker of thyroid status. The combination of falling TSH with modulated T3 and T4 suggests that Ujjayi practice may enhance the body's sensitivity to circulating thyroid hormones, reducing the pituitary's demand signal. The Venkateswaran trial provided complementary data showing T3 increased significantly in the yoga group, while T4 showed a non-significant upward trend, suggesting that longer intervention duration may yield different hormonal dynamics .

Body Mass Index and Body Weight Reduced Significantly

Both studies reported significant reductions in body weight and BMI following the Ujjayi intervention . This finding carries clinical significance because weight gain and difficulty losing weight are among the most distressing and persistent symptoms reported by hypothyroid patients. Thyroid hormones are primary regulators of basal metabolic rate. Improved thyroid function, even subtle improvement within the normal range, would be expected to increase resting energy expenditure and facilitate weight loss. The autonomic shift toward parasympathetic dominance may also reduce stress-induced eating and cortisol-driven central adiposity.

Autonomic Function Improved in Complementary Trial

The 2025 randomized trial assessing yoga therapy in hypothyroid women provided evidence that pranayama practice enhances cardiac autonomic function. After three months, yoga group participants showed significant increases in heart rate variability parameters reflecting parasympathetic tone, including SDNN, RMSSD, and high-frequency power. Resting sympathetic activity declined significantly, and baroreflex sensitivity improved. Cardiovascular parameters including systolic blood pressure, diastolic blood pressure, and rate-pressure product all improved significantly compared to the medication-only control group . These autonomic improvements provide a plausible physiological mechanism through which Ujjayi pranayama may exert its thyroid-modulating effects.

Effects Occurred Within a Short Intervention Window

The Thenmozhi and Cathrin study demonstrated measurable thyroid and BMI changes within just four weeks . The Venkateswaran trial produced more pronounced results over 12 weeks . This relatively rapid onset of effect distinguishes Ujjayi pranayama from many lifestyle interventions that require months or years to produce detectable physiological changes. The brief intervention period also makes Ujjayi practice a practical, accessible adjunctive therapy that fits within clinical treatment timeframes.

4. Lessons Learnt

Breath is a physiologically potent intervention, not merely a relaxation tool.

The most fundamental lesson emerging from this research is that structured breathing practices produce measurable, statistically significant changes in endocrine function, not merely subjective feelings of calm. The reduction in TSH and BMI achieved through Ujjayi pranayama demonstrates that conscious breath regulation accesses neuroendocrine pathways that influence metabolism and hormonal balance.

The throat is an anatomical site of therapeutic convergence.

Ujjayi pranayama involves deliberate, gentle constriction of the glottis, generating vibration and altered pressure dynamics in the throat region. This is the precise anatomical location of the thyroid gland. While the mechanism remains partially understood, the convergence of the practice's physical focus with the target organ's anatomical location suggests that localized effects, including enhanced blood flow and vagal stimulation, may contribute to the observed thyroid benefits.

Autonomic rebalancing may be the mechanistic bridge.

The finding that yoga therapy shifts hypothyroid patients from sympathetic overactivity toward parasympathetic predominance provides a plausible mechanistic pathway . Thyroid function is modulated by autonomic input. Sympathetic overdrive, characteristic of the hypothyroid state, may further impair thyroid hormone synthesis and conversion. By restoring parasympathetic tone, Ujjayi breathing may create an autonomic environment more favorable to optimal thyroid axis function.

Complementary therapy can add value beyond pharmacological normalization.

The patients in these studies were already receiving standard levothyroxine therapy, yet the addition of Ujjayi pranayama produced further improvements in TSH, body weight, and autonomic function. This suggests that while medication normalizes hormone levels, breath-based practices address broader physiological dysregulation that medication alone may not fully resolve. The improvements in quality of life and reductions in psychological symptoms reported in the broader yoga-thyroid literature further support this conclusion .

Small sample sizes and short durations limit current confidence.

The primary Thenmozhi and Cathrin study involved only 30 participants followed for four weeks. Even the larger Venkateswaran trial, with 120 participants across 12 weeks, represents a modest evidence base compared to the multi-thousand-participant, multi-year trials that inform pharmaceutical therapy. The broader systematic review of yoga for thyroid disease identified only 13 studies meeting inclusion criteria for qualitative analysis, with most focused on hypothyroidism . The authors themselves consistently note that larger, longer-duration randomized controlled trials are needed to establish the generalizability and durability of effects .

5. How This Research Can Help Humanity

Providing an Accessible, Low-Cost Adjunctive Therapy

Ujjayi pranayama requires no equipment, no financial expenditure, and no clinical infrastructure. Once learned, it can be practiced anywhere and at any time. For the millions of hypothyroid patients worldwide, particularly those in resource-limited settings where access to specialist care is limited, a breathing practice that demonstrably improves TSH, BMI, and autonomic function represents an accessible complement to medication that empowers patients to participate actively in their own health management.

Addressing Residual Symptoms Despite Biochemical Control

The persistent symptom burden experienced by many hypothyroid patients on levothyroxine, including fatigue, brain fog, and weight retention, constitutes a significant quality-of-life burden. By improving autonomic function, reducing BMI, and potentially enhancing cellular sensitivity to thyroid hormones, Ujjayi pranayama may address aspects of the hypothyroid syndrome that medication alone does not resolve.

Reducing Cardiovascular Risk in a Vulnerable Population

Hypothyroidism independently increases cardiovascular disease risk, and the sympathovagal imbalance characteristic of the condition compounds this risk . The demonstration that yoga therapy significantly improves heart rate variability, baroreflex sensitivity, and blood pressure in hypothyroid patients suggests that Ujjayi pranayama may serve a cardioprotective role. For a population already at elevated risk for heart disease, this non-pharmacological autonomic modulation could have long-term health implications extending beyond thyroid function alone.

Contributing to the Scientific Validation of Traditional Practices

Ujjayi pranayama has been practiced for thousands of years within yogic traditions, but its acceptance within mainstream clinical medicine requires rigorous scientific evidence. Studies such as these, while modest in scale, contribute incrementally to the evidence base that supports integration of breath-based practices into clinical guidelines for endocrine disorders.

Opening Avenues for Mind-Body Approaches Across Endocrine Conditions

The thyroid findings, combined with established yoga benefits for diabetes and metabolic syndrome, suggest that breath-based autonomic modulation may have broad applicability across endocrine disorders. Future research may extend the Ujjayi protocol to subclinical hypothyroidism, hyperthyroidism, postpartum thyroiditis, and thyroid autoimmunity.

6. Final Summary

Most Important Takeaways

1. Ujjayi pranayama produced significant TSH and BMI reductions in hypothyroid patients.

Across multiple studies with varying durations and sample sizes, the consistent finding was that structured Ujjayi pranayama practice, when added to standard pharmacological therapy, yielded statistically significant improvements in the key clinical markers of TSH and body weight . The magnitude of change, while modest in absolute terms, was sufficient to achieve statistical significance and clinical relevance.

2. Autonomic rebalancing provides a biologically plausible mechanism.

The demonstration that yoga therapy shifts hypothyroid patients from sympathetic predominance toward parasympathetic balance, with measurable improvements in heart rate variability and baroreflex sensitivity, establishes a credible mechanistic pathway linking breath practice to endocrine effect . The throat's dual role as the site of Ujjayi's physical practice and the anatomical location of the thyroid gland strengthens this connection.

3. Effects were achieved within weeks, not months.

The Thenmozhi and Cathrin study demonstrated measurable changes within four weeks, while the Venkateswaran trial showed more pronounced benefits over 12 weeks . This relatively rapid onset suggests that Ujjayi pranayama engages existing physiological pathways rather than requiring lengthy structural remodeling, making it a practical clinical adjunct.

4. The intervention addresses the whole patient, not just the laboratory value.

Beyond thyroid profile changes, the broader yoga-thyroid literature documents improvements in psychological symptoms including stress, anxiety, and depression, as well as quality of life . This holistic effect profile, combining endocrine, metabolic, autonomic, and psychological benefits, is a distinctive feature of mind-body interventions that complements the targeted action of pharmacological therapy.

5. Current evidence is promising but preliminary.

The studies reviewed are limited by small sample sizes, relatively short intervention periods, and in some cases, single-group designs without control arms. A systematic review of yoga for thyroid disease concluded that while beneficial effects are evident, more randomized controlled trials with larger samples are needed before definitive clinical recommendations can be made .

Action Points

For Hypothyroid Patients:

· Learn Ujjayi pranayama from a qualified instructor. The technique involves gentle glottic constriction producing a soft oceanic sound during both inhalation and exhalation. Proper instruction ensures correct practice and minimizes risk of dizziness or hyperventilation.

· Practice consistently. The study protocols involved twice-daily practice of approximately 15 minutes each session, six days per week, for 4 to 12 weeks. Regular, sustained practice appears necessary for measurable physiological benefit.

· Continue prescribed medication. Ujjayi pranayama is studied as an adjunctive, not a replacement, therapy. Thyroid medication should never be altered or discontinued without medical supervision.

· Monitor thyroid function. Inform your healthcare provider about your yoga practice and request thyroid function testing at appropriate intervals to assess response.

For Healthcare Providers:

· Consider recommending Ujjayi pranayama as a complementary intervention. For motivated hypothyroid patients with residual symptoms or persistent weight concerns, a structured breath practice may offer additional benefit beyond medication optimization.

· Set realistic expectations. The magnitude of TSH and BMI change, while statistically significant, is modest. Frame Ujjayi pranayama as a supportive practice that may improve overall well-being and metabolic function rather than a cure or replacement for medication.

· Be aware of autonomic function. The cardiovascular and autonomic benefits of yoga therapy may be as clinically meaningful as the thyroid effects, particularly given the elevated cardiovascular risk in the hypothyroid population .

For Yoga Therapists and Instructors:

· Seek training in therapeutic applications. Teaching Ujjayi pranayama to clinical populations requires understanding of the underlying pathophysiology and awareness of precautions.

· Collaborate with medical providers. Establish communication channels with patients' endocrinologists or primary care physicians to integrate yoga therapy safely into comprehensive treatment plans.

· Track outcomes systematically. Maintain records of practice adherence and patient-reported outcomes to contribute to the growing evidence base.

For Researchers:

· Conduct larger, long-term randomized controlled trials. Studies with several hundred participants followed for six to twelve months are needed to confirm the effects observed in smaller trials and to assess durability.

· Include mechanistic measures. Future studies should simultaneously assess thyroid function, autonomic parameters, inflammatory markers, and quality-of-life outcomes to elucidate the interconnected physiological pathways through which Ujjayi pranayama exerts its effects.

· Investigate dose-response relationships. Determine the optimal frequency, duration, and intensity of Ujjayi practice for thyroid benefit.

· Extend to other thyroid conditions. Evaluate whether Ujjayi pranayama benefits patients with subclinical hypothyroidism, hyperthyroidism, and thyroid autoimmunity.

-x-x-

Recommended Follow-Up Study

A Multi-Centre Randomized Controlled Trial of Ujjayi Pranayama for Hypothyroidism with Mechanistic Outcomes

The existing evidence, while encouraging, lacks a definitive trial that would establish Ujjayi pranayama as an evidence-based adjunctive therapy for hypothyroidism. A multi-centre randomized controlled trial enrolling 300 to 400 hypothyroid patients on stable levothyroxine therapy is the critical next step. Participants would be randomized to three arms: a Ujjayi pranayama group receiving standardized, video-verified instruction with twice-daily home practice, an active control group performing slow-paced breathing without glottic constriction to control for attention and breathing rhythm effects, and a usual-care control group. The intervention period would extend for six months with follow-up at 12 months to assess durability. Primary outcomes would include TSH, free T3, free T4, and BMI. Secondary outcomes would encompass heart rate variability, baroreflex sensitivity, inflammatory cytokines, anti-thyroid antibody titers, quality-of-life measures, and levothyroxine dose requirements. Thyroid ultrasound with Doppler flow assessment would provide mechanistic insight into potential changes in glandular vascularity. This trial would provide the high-quality evidence needed to inform clinical guidelines and potentially establish Ujjayi pranayama as a standard complementary recommendation in endocrine practice.

List of Other Related / Connected Studies and Research

The 12-Week Yoga Therapy and Autonomic Function Trial (JIPMER, 2025)

This randomized controlled trial of 99 hypothyroid women demonstrated that three months of yoga therapy significantly improved cardiac autonomic function, shifting the sympathovagal balance toward parasympathetic predominance and enhancing baroreflex sensitivity. Cardiovascular parameters including blood pressure and rate-pressure product also improved significantly. This study provides the mechanistic underpinning for the thyroid effects observed in the Ujjayi-specific trials, establishing that autonomic modulation is a key pathway through which yoga practice benefits hypothyroid patients .

The Venkateswaran Randomized Controlled Trial of Ujjayi Pranayama (2019)

A 12-week study with 120 participants that demonstrated significant improvements in T3, TSH, body weight, and BMI in the Ujjayi group compared to controls receiving medication only. T4 showed a non-significant upward trend. This trial, with its larger sample and longer duration, provides the strongest available evidence specific to Ujjayi pranayama for hypothyroidism .

The Systematic Review of Yoga for Thyroid Disease (Chakraborty et al., 2025)

A comprehensive systematic review that identified 13 studies for qualitative analysis, with nine of those focused on hypothyroidism. The review found that the most common yoga practices employed were suryanamaskara, specific asanas including bhujangasana and sarvangasana, and pranayama techniques including ujjayi, anulomvilom, bhastrika, and bhramari. The review concluded that yoga demonstrates beneficial effects in managing hypothyroidism symptoms but that more rigorous trials are needed .

The 6-Month Yoga and Adipokine Study for Obese Hypothyroid Patients

A study demonstrating that six months of yoga and pranayama practice resulted in significant reductions in serum leptin, lipoprotein(a), BMI, and blood pressure, along with improved adiponectin levels and thyroid function. This longer-duration study provides evidence that sustained practice yields progressive and broader metabolic benefits .

The MATADOR Study, Glucose-Willpower Model, and Perceived Self-Efficacy Studies

Earlier monographs in this series explored themes of metabolic adaptation and self-regulation. The Ujjayi findings extend this conceptual arc into neuroendocrine modulation. Just as MATADOR demonstrated that strategic diet breaks can attenuate adaptive thermogenesis, Ujjayi pranayama may attenuate the autonomic dysfunction that accompanies and exacerbates hypothyroidism. The breath becomes a tool for consciously modulating a physiological control system, a parallel to how structured dietary patterns modulate metabolic control systems.